PsychonautDream

The most famous psychedelic brain images are seductively simple: colored networks bloom across a dark background, and a caption announces that scientists have finally found the biological source of transcendence. The pictures are real measurements transformed into visualizations. The caption is usually doing too much work. Psychedelic neuroscience is advancing rapidly, but it is not a machine for translating every vision into a neat diagram.

Start with the receptor, not the rainbow

Classic psychedelics such as psilocybin, LSD, and DMT are pharmacologically distinct but share an important mechanism: agonist activity at serotonin 5-HT2A receptors. These receptors are abundant in parts of the cortex and participate in complex signaling systems. Their activation is strongly implicated in the characteristic effects of classic psychedelics, though receptor binding alone does not specify the content of a particular experience.

A chemical’s action also depends on dose, timing, metabolism, receptor selectivity, and the biological state of the person receiving it. “Serotonin-like” is a starting point, not an explanation. LSD has a different pharmacokinetic profile from DMT; psilocybin is converted to psilocin. Treating all psychedelic compounds as one undifferentiated category obscures mechanisms worth studying.

What functional connectivity measures

Functional MRI detects changes associated with blood oxygenation, an indirect proxy for aspects of neural activity. Researchers use it to estimate how activity fluctuates across regions and networks. When papers describe greater or lesser “connectivity,” they are usually discussing statistical relationships in those signals—not new physical wires growing between brain areas.

The 2012 Carhart-Harris psilocybin study illustrates the need for precision: it used two imaging approaches with separate groups of 15 healthy volunteers, observing reductions in cerebral blood flow and BOLD signals in specific hub regions, not a global shutdown of the brain. Its finding of reduced coupling between medial prefrontal and posterior cingulate regions is a measured association under particular experimental conditions, not proof that one network constitutes the self. (Carhart-Harris et al., 2012.)

EEG and MEG, by contrast, measure electrical or magnetic signatures of neural activity with different strengths and limitations. Combining methods can improve temporal and spatial interpretation, but every method has artifacts, assumptions, and analytical choices. A vivid connectome graphic is the final product of a pipeline, not an unmediated photograph of consciousness.

The default mode network: useful, overmarketed

The default mode network is associated with several forms of internally directed thought, including autobiographical processes. Psychedelic studies have documented changes involving this network, and some findings correlate with reports of altered self-experience. But the claim that the default mode network simply is the ego is false precision. The network participates in many processes, and selfhood is distributed across interacting systems.

Similarly, the idea that psychedelics “switch off” the brain is misleading. A reduction in one measured pattern can coexist with an increase in another. Depending on the substance, method, and experimental context, researchers may observe altered oscillations, changed connectivity, or greater integration between systems that are normally more segregated.

Entropy, prediction, and the danger of a beautiful theory

One influential family of models proposes that psychedelic states change the flexibility or diversity of brain dynamics. Another emphasizes predictive processing: perception is shaped not only by sensory inputs but by the brain’s expectations about what those inputs mean. If the weighting of high-level expectations changes, perception and belief may become unusually fluid.

These frameworks help generate hypotheses. They do not yet offer a complete account of why one person experiences geometric forms, another revisits autobiographical memories, and a third reports an encounter with an autonomous being. A theory becomes stronger when it predicts differences among conditions and survives experiments designed to disconfirm it—not when it can be applied poetically to every possible outcome.

Neuroplasticity is not a magic synonym for healing

Research has investigated whether psychedelic compounds can influence markers of structural or functional plasticity. Ly and colleagues (2018) reported changes in neurite growth, dendritic spines, synaptic markers and electrophysiological measures using cell-based experiments and animal models, including rat prefrontal-cortex measurements after DMT exposure. This is mechanistic, preclinical evidence—not a clinical trial demonstrating that psychedelics repair the human brain. Cell-culture and animal findings do not automatically establish lasting clinical benefits in humans. Nor does a change in a plasticity marker tell us whether a new habit, belief, or behavior will be healthy.

Clinical outcomes involve more than pharmacology. Participants may receive preparation, structured support, follow-up, and other forms of care. Expectation and the difficulty of maintaining blinding are major methodological challenges. It is therefore inaccurate to attribute every reported improvement solely to a molecule—or to claim that a brain scan proves psychotherapy has become unnecessary.

What the brain scans can tell us—and what they cannot

A neural scan is not a photograph of a thought. Functional MRI estimates changes in blood oxygenation associated with neural processes, and investigators use those signals to infer patterns across brain networks. This is scientifically powerful, but it introduces several steps between a recorded signal and a claim about someone’s subjective experience.

The spectacular connectivity diagrams that circulate online flatten those steps into one image. A brightly connected network may look like consciousness has been switched on; a fragmented map may look like the self is dissolving. In reality, a visualization often depends on preprocessing, mathematical definitions, thresholds, study design and a choice about what to display. The colors are a language for communicating measurements, not the brain’s native palette.

This matters because psychedelic consciousness is unusually easy to romanticize. We have good reasons to ask which neural changes accompany alterations of perception and selfhood. We do not need to claim that a colorful rendering has finally photographed enlightenment.

The seven-person study that revealed a more dynamic picture

A 2024 study in Nature used intensive repeated brain mapping to examine psilocybin’s effects on functional organization in seven adults. The researchers observed substantial acute desynchronization of brain activity and changes in interactions among normally distinct networks. Some connectivity changes were detectable after the immediate drug effects, though the pattern and duration were not uniform across every analysis.

It is an intriguing result, especially because the researchers could compare individual participants against their own densely sampled baselines. The precision of repeated measurement partly offsets the limitations of a small sample, but it does not turn seven participants into a representative sample of everyone who might use psilocybin.

Nor does desynchronization mean that the brain simply became random. The term refers to measurable changes in how activity patterns align or covary. That is not an invitation to conclude that people with “more chaotic” brain scans have achieved a higher form of consciousness. The relationship between neural dynamics and reported meaning has to be studied, not assumed.

The National Institutes of Health research summary provides an accessible account of the experiment and its cautions.

The 2026 context finding complicates the chaos story

An important 2026 Nature study investigated how brain dynamics under psilocybin change in different contexts. Its team used multimodal imaging and varied conditions—including rest, meditation, music and audiovisual stimulation—among 62 psychedelic-naive participants. The reported changes were not merely a global loss of organization. The dynamics became more sensitive to the situation in which the person was experiencing them.

This is fascinating because it suggests that an altered state may change how the brain responds to its surroundings, rather than simply turning down an internal control system. The authors described structured, context-sensitive patterns associated with aspects of subjective experience. That does not establish that a particular song or meditation technique produces a predictable clinical outcome. It offers a more refined question about the relationship between neural organization and the world the person inhabits.

For psychonauts, there is an obvious resonance with the old emphasis on set and setting. The resemblance should be treated carefully: a neuroimaging experiment is not proof of every historical claim about set and setting. Still, it shows why reducing the experience to a molecule alone is incomplete. The set-and-setting discussion explores that wider context.

Receptor biology does not dictate the content of a vision

Classic serotonergic psychedelics have important effects involving 5-HT2A receptors, but that common pharmacological entry point does not determine whether a person experiences geometric imagery, emotional recollection, unusual social insight or an encounter with a seemingly autonomous figure. The content of experience also depends on memory, expectation, bodily state, environment and many processes that are not captured by a single receptor diagram.

At the cellular level, animal and laboratory studies have investigated how psychedelic compounds influence synaptic and dendritic plasticity. A 2025 Nature study identified particular pyramidal-cell populations and 5-HT2A signaling as important to certain longer-term psilocybin effects. The finding helps locate candidate mechanisms; it does not prove that every subjective revelation corresponds to a beneficial structural change.

Another study in Science examined the role of intracellular 5-HT2A receptors in promoting neural plasticity. These experiments are valuable precisely because they move beyond slogans toward testable molecular questions. But moving from cell changes to improvements in depression or long-term personal transformation requires additional clinical evidence.

Does neuroscience eliminate the mystery of consciousness?

Explaining a mechanism and explaining the entire meaning of an experience are different tasks. Neuroimaging can help determine what changes when someone experiences altered time, unusual embodiment or a weakened sense of self. It cannot, by itself, decide whether a powerful symbol should be interpreted through Jungian psychology, religious language, autobiography, cultural expectation or some combination of these.

There is no need to force a choice between taking the brain seriously and taking subjective experience seriously. The nervous system is an essential part of the evidence. First-person reports are also data about what people experienced, although they are not automatic proof of the external reality of everything encountered.

Donald Hoffman’s work on perception offers a provocative philosophical lens: our experience of reality may be a construction useful for navigation rather than a transparent reproduction of the world. That proposal is not established by a psilocybin scan. The intellectually fertile connection is the question it inspires: how does the brain ordinarily stabilize perception, and what happens when that stabilization changes?

For related first-person questions, see altered states of consciousness and reports of DMT entities. Neuroscience should sharpen how we investigate such reports, not reduce them to a punchline or turn them into proof of another dimension.

The most useful questions now

Which neural changes persist beyond the immediate experience? How reliable are they across individuals? Which patterns depend on the environment? How much of the reported therapeutic effect can be separated from expectancy and psychological support? Which receptor and cellular mechanisms are necessary, and which are merely correlated with observed changes?

These questions demand larger samples, independently replicated experiments, careful clinical follow-up and clear distinctions between causal mechanisms and associations. It is possible that future studies will provide more precise accounts of how psychedelics alter perception, learning and emotional processing. It is also possible that some current theories will need substantial revision.

The reward is not a less mysterious universe. It is a set of increasingly exact ways to investigate one. We do not have to replace wonder with certainty. We can replace vague claims with better questions and let the results surprise us.

What research can explain about extraordinary experiences

Neuroscience can identify mechanisms, correlates, and constraints. It can test whether certain neural patterns accompany changes in time perception, sensory processing, or self-boundaries. It cannot currently adjudicate the metaphysical status of a perceived entity or determine whether a mystical insight is true. Subjective reports remain important data, but they must be interpreted alongside objective measures without confusing the two.

The most interesting future studies will combine careful phenomenology, pharmacology, longitudinal outcomes, and rigorous controls. They will ask not only what changed in the brain? but which change predicts which aspect of experience, for whom, and under what conditions? That is a harder question than the viral image promises—and a far better one.

Continue reading: Ego Death · Introduction to DMT · Psychedelics and Mystical Experiences

Selected research and further reading – Nichols D.E. (2016), “Psychedelics,” Pharmacological Reviews. https://doi.org/10.1124/pr.115.011478 (Review; corrected Figure 4 in publisher erratum: https://doi.org/10.1124/pr.114.011478err) – Halman A., Kong G., Sarris J. and Perkins D. (2024), “Drug–drug interactions involving classic psychedelics: A systematic review,” Journal of Psychopharmacology 38(1):3–18. https://doi.org/10.1177/02698811231211219 (52 studies from 36 reports; heterogeneous evidence) – Carhart-Harris R.L. et al. (2012), “Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin,” PNAS. https://doi.org/10.1073/pnas.1119598109 – Timmermann C. et al. (2023), “Human brain effects of DMT assessed via EEG-fMRI,” PNAS. https://doi.org/10.1073/pnas.2218949120 – Ly C. et al. (2018), “Psychedelics Promote Structural and Functional Neural Plasticity,” Cell Reports. https://doi.org/10.1016/j.celrep.2018.05.022

Key concepts

Brief definitions for terms used in this article.

5-HT2A

A serotonin receptor subtype involved in the effects of several classic psychedelics.

default mode network

A set of interacting brain regions often studied during internally oriented thought. It is not a single brain switch.

serotonin

A signaling molecule involved in many functions throughout the brain and body.

neuroplasticity

The capacity of neural systems to change over time through experience, learning or other influences.

mystical experience

A term researchers may use for certain self-reported experiences of unity, significance or transcendence, not proof of supernatural claims.

The Rabbit Hole

Where to next?

Follow a real editorial connection, or return to the Library.

← All Articles
More reading tools